Ken Griffin’s Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share CLBR.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-357,344
Closed -$1.34M 12891
2025
Q2
$1.34M Buy
357,344
+257,546
+258% +$578K ﹤0.01% 6478
2025
Q1
$79.8K Buy
+99,798
New +$90.2K ﹤0.01% 11765

Ken Griffin's CLBR.WS Position: Q3 2025 in Review

Ken Griffin sold out of Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share (CLBR.WS) in Q3 2025, closing a stake of 357,344 shares — an estimated $1.34M sold.

Ken Griffin first reported a position in CLBR.WS in Q1 2025 and held it in 2 quarters. The position peaked at $1.34M in Q2 2025. 0 funds tracked by Wall St. Rank hold CLBR.WS as of Q3 2025.

  • Ken Griffin reported no remaining Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position as of Q3 2025 after selling out during the quarter.
  • Ken Griffin sold 357,344 Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share shares in Q3 2025, an estimated $1.34M.
  • Ken Griffin first reported a position in Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share in Q1 2025 and held it in 2 quarters.
  • Ken Griffin's Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position peaked at $1.34M in Q2 2025.
  • 0 funds tracked by Wall St. Rank held Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.